SYNBIAS PHARMA AG
Overview
SYNBIAS PHARMA AG is an active pharmaceutical ingredient (API) supplier with 5 active FDA Type II Drug Master Files, covering DOXORUBICIN HYDROCHLORIDE; EPIRUBICIN HYDROCHLORIDE; IDARUBICIN HCL; NELARABINE; VALRUBICIN USP.
Core services & business areas
Active pharmaceutical ingredients supplied
Substances SYNBIAS PHARMA AG is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.
API / Drug Master Files
SYNBIAS PHARMA AG holds 5 active (10 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- IDARUBICIN HCLActive2021-12-02
- NELARABINEActive2016-05-25
- VALRUBICIN USPActive2013-02-26
- EPIRUBICIN HYDROCHLORIDEActive2002-10-31
- DOXORUBICIN HYDROCHLORIDEActive2002-10-09
- CLOFARABINEInactive2015-05-11
- VINORELBINE TARTRATEInactive2014-05-06
- TOPOTECAN HYDROCHLORIDEInactive2010-03-29
- VINORELBINE TARTRATEInactive2008-09-01
- IDARUBICIN HYDROCHLORIDEInactive2004-06-26
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to SYNBIAS PHARMA AG in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this SYNBIAS PHARMA AG? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.